Edwards Lifesciences (EW) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1 890 | 1 960 | 1 535 | 1 723 | 1 430 | 1 436 | ||
| Changes by years, y/y, % | +76% | +4% | -22% | +12% | -17% | +5.9% | |||
Edwards Lifesciences. EBITDA US GAAP, bln rub
Edwards Lifesciences. EBITDA US GAAP, changes, %
Edwards Lifesciences. EBITDA US GAAP, sum by quarters, bln rub
Edwards Lifesciences (EW) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 470.5 | 400.2 | 387.6 | 133.1 | 459.0 | 1 436 | |
| Changes by years, y/y, % | +15% | -6% | -10% | -72% | -2% | |||
| Changes by quarters, q/q, % | -3% | -15% | -3% | -66% | +245% | |||